In their prospective study, Kuten et al. compared the diagnostic accuracy of 18F-PSMA-1007 with that of 68Ga-PSMA-11 in 16 males newly diagnosed with intermediate- to high-risk PCa, and demonstrated that both tracers detected all prominent lesions in patients and 18F-PSMA-1007 detected additional low-grade lesions of limited clinical relevance [43]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.